111 related articles for article (PubMed ID: 12482546)
1. Patterns of oxidized epitopes, but not NF-kappa B expression, change during atherogenesis in WHHL rabbits.
Bräsen JH; Häkkinen T; Malle E; Beisiegel U; Ylä-Herttuala S
Atherosclerosis; 2003 Jan; 166(1):13-21. PubMed ID: 12482546
[TBL] [Abstract][Full Text] [Related]
2. Expression of extracellular SOD and iNOS in macrophages and smooth muscle cells in human and rabbit atherosclerotic lesions: colocalization with epitopes characteristic of oxidized LDL and peroxynitrite-modified proteins.
Luoma JS; Strålin P; Marklund SL; Hiltunen TP; Särkioja T; Ylä-Herttuala S
Arterioscler Thromb Vasc Biol; 1998 Feb; 18(2):157-67. PubMed ID: 9484979
[TBL] [Abstract][Full Text] [Related]
3. ApoE-deficient mice are a model of lipoprotein oxidation in atherogenesis. Demonstration of oxidation-specific epitopes in lesions and high titers of autoantibodies to malondialdehyde-lysine in serum.
Palinski W; Ord VA; Plump AS; Breslow JL; Steinberg D; Witztum JL
Arterioscler Thromb; 1994 Apr; 14(4):605-16. PubMed ID: 7511933
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical evidence for the myeloperoxidase/H2O2/halide system in human atherosclerotic lesions: colocalization of myeloperoxidase and hypochlorite-modified proteins.
Malle E; Waeg G; Schreiber R; Gröne EF; Sattler W; Gröne HJ
Eur J Biochem; 2000 Jul; 267(14):4495-503. PubMed ID: 10880973
[TBL] [Abstract][Full Text] [Related]
5. Presence of hypochlorite-modified proteins in human atherosclerotic lesions.
Hazell LJ; Arnold L; Flowers D; Waeg G; Malle E; Stocker R
J Clin Invest; 1996 Mar; 97(6):1535-44. PubMed ID: 8617887
[TBL] [Abstract][Full Text] [Related]
6. Distribution of oxidation specific lipid-protein adducts and apolipoprotein B in atherosclerotic lesions of varying severity from WHHL rabbits.
Rosenfeld ME; Palinski W; Ylä-Herttuala S; Butler S; Witztum JL
Arteriosclerosis; 1990; 10(3):336-49. PubMed ID: 1693069
[TBL] [Abstract][Full Text] [Related]
7. Radiolabeled MDA2, an oxidation-specific, monoclonal antibody, identifies native atherosclerotic lesions in vivo.
Tsimikas S; Palinski W; Halpern SE; Yeung DW; Curtiss LK; Witztum JL
J Nucl Cardiol; 1999; 6(1 Pt 1):41-53. PubMed ID: 10070840
[TBL] [Abstract][Full Text] [Related]
8. Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL.
Ylä-Herttuala S; Palinski W; Butler SW; Picard S; Steinberg D; Witztum JL
Arterioscler Thromb; 1994 Jan; 14(1):32-40. PubMed ID: 7506053
[TBL] [Abstract][Full Text] [Related]
9. Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein.
Palinski W; Ylä-Herttuala S; Rosenfeld ME; Butler SW; Socher SA; Parthasarathy S; Curtiss LK; Witztum JL
Arteriosclerosis; 1990; 10(3):325-35. PubMed ID: 1693068
[TBL] [Abstract][Full Text] [Related]
10. [Modified lipoproteins in atherosclerotic lesions of human aorta].
Wang X; Chen Q; Zhu Q
Zhonghua Bing Li Xue Za Zhi; 1998 Feb; 27(1):6-9. PubMed ID: 11244945
[TBL] [Abstract][Full Text] [Related]
11. Immunostaining of human autopsy aortas with antibodies to modified apolipoprotein B and apoprotein(a).
Jürgens G; Chen Q; Esterbauer H; Mair S; Ledinski G; Dinges HP
Arterioscler Thromb; 1993 Nov; 13(11):1689-99. PubMed ID: 7692957
[TBL] [Abstract][Full Text] [Related]
12. Studies on epitopes on low-density lipoprotein modified by 4-hydroxynonenal. Biochemical characterization and determination.
Chen Q; Esterbauer H; Jürgens G
Biochem J; 1992 Nov; 288 ( Pt 1)(Pt 1):249-54. PubMed ID: 1280111
[TBL] [Abstract][Full Text] [Related]
13. Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia. Intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions.
Napoli C; D'Armiento FP; Mancini FP; Postiglione A; Witztum JL; Palumbo G; Palinski W
J Clin Invest; 1997 Dec; 100(11):2680-90. PubMed ID: 9389731
[TBL] [Abstract][Full Text] [Related]
14. Hypochlorite-modified (lipo)proteins are present in rabbit lesions in response to dietary cholesterol.
Malle E; Wäg G; Thiery J; Sattler W; Gröne HJ
Biochem Biophys Res Commun; 2001 Dec; 289(4):894-900. PubMed ID: 11735131
[TBL] [Abstract][Full Text] [Related]
15. Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma.
Palinski W; Hörkkö S; Miller E; Steinbrecher UP; Powell HC; Curtiss LK; Witztum JL
J Clin Invest; 1996 Aug; 98(3):800-14. PubMed ID: 8698873
[TBL] [Abstract][Full Text] [Related]
16. Immunological evidence for the presence of advanced glycosylation end products in atherosclerotic lesions of euglycemic rabbits.
Palinski W; Koschinsky T; Butler SW; Miller E; Vlassara H; Cerami A; Witztum JL
Arterioscler Thromb Vasc Biol; 1995 May; 15(5):571-82. PubMed ID: 7749871
[TBL] [Abstract][Full Text] [Related]
17. Low density lipoprotein oxidation and atherogenesis: from experimental models to clinical studies.
Napoli C
G Ital Cardiol; 1997 Dec; 27(12):1302-14. PubMed ID: 9470066
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical localization of different epitopes of advanced glycation end products in human atherosclerotic lesions.
Sakata N; Imanaga Y; Meng J; Tachikawa Y; Takebayashi S; Nagai R; Horiuchi S; Itabe H; Takano T
Atherosclerosis; 1998 Nov; 141(1):61-75. PubMed ID: 9863539
[TBL] [Abstract][Full Text] [Related]
19. Macrophage colony-stimulating factor gene expression in vascular cells and in experimental and human atherosclerosis.
Clinton SK; Underwood R; Hayes L; Sherman ML; Kufe DW; Libby P
Am J Pathol; 1992 Feb; 140(2):301-16. PubMed ID: 1739124
[TBL] [Abstract][Full Text] [Related]
20. Immunological responses to oxidized LDL.
Hörkkö S; Binder CJ; Shaw PX; Chang MK; Silverman G; Palinski W; Witztum JL
Free Radic Biol Med; 2000 Jun; 28(12):1771-9. PubMed ID: 10946219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
